Table III.

Multivariate models for SOS (m/s) and BUA (dB/MHz) measures performed in 2002

Main exposure variable		SOSa			BUAb
PUFA	N	R2	Regression coefficient (SE)	p-value	R2	Regression coefficient (SE)	p-value
ALAc	115	0.8452	0.805 (9.999)	0.9360	0.7230	−4.506 (6.277)	0.4745
ALAd	115	0.8503	3.130 (8.622)	0.7173	0.7156	−9.942 (5.584)	0.0780
ALAe	115	0.8447	−2.199 (8.325)	0.7922	0.7156	−10.313 (5.299)	0.0544
ALAf	115	0.8473	5.850 (10.315)	0.5718	0.7207	−4.880 (6.545)	0.4576
EPAc	116	0.8451	0.276 (0.545)	0.6140	0.7311	0.654 (0.340)	0.0569
EPAd	116	0.8495	0.123 (0.343)	0.7205	0.7311	0.648 (0.218)	0.0036
EPAe	116	0.8451	0.277 (0.343)	0.4213	0.7325	0.685 (0.214)	0.0019
EPAf	116	0.8465	−0.106 (0.526)	0.8414	0.7312	0.695 (0.329)	0.0369
DHAc	116	0.8447	−0.053 (0.851)	0.9506	0.7226	0.364 (0.535)	0.4984
DHAd	116	0.8494	0.132 (0.525)	0.8023	0.7211	0.744 (0.338)	0.0297
DHAe	116	0.8444	0.243 (0.546)	0.6569	0.7212	0.824 (0.346)	0.0189
DHAf	116	0.8470	−0.473 (0.762)	0.5367	0.7220	0.472 (0.485)	0.3328
Σomega-3 HPFAc	116	0.8450	0.163 (0.404)	0.6870	0.7296	0.444 (0.251)	0.0799
Σomega-3 HPFAd	116	0.8495	0.073 (0.211)	0.7294	0.7296	0.384 (0.134)	0.0050
Σomega-3 HPFAe	116	0.8450	0.160 (0.214)	0.4563	0.7310	0.414 (0.134)	0.0025
Σomega-3 HPFAf	116	0.8467	−0.165 (0.367)	0.6533	0.7297	0.454 (0.230)	0.0506
Σomega-3 PUFAc	116	0.8449	0.153 (0.411)	0.7100	0.7292	0.440 (0.256)	0.0880
Σomega-3 PUFAd	116	0.8495	0.072 (0.214)	0.7361	0.7292	0.386 (0.136)	0.0054
Σomega-3 PUFAe	116	0.8450	0.159 (0.217)	0.4662	0.7307	0.417 (0.136)	0.0027
Σomega-3 PUFAf	116	0.8467	−0.176 (0.371)	0.6357	0.7293	0.450 (0.233)	0.0559
LAg	116	0.8467	−0.464 (0.435)	0.2884	0.7297	0.092 (0.273)	0.7375
LAh	116	0.8465	−0.362 (0.386)	0.3501	0.7312	0.039 (0.242)	0.8720
LAi	116	0.8470	−0.462 (0.356)	0.1973	0.7220	−0.192 (0.228)	0.4013
LAj	115	0.8473	−0.403 (0.309)	0.1943	0.7207	−0.270 (0.196)	0.1720
AAg	116	0.8495	1.410 (0.803)	0.0822	0.7296	0.114 (0.509)	0.8227
AAh	116	0.8495	1.399 (0.809)	0.0866	0.7311	0.061 (0.511)	0.9047
AAi	116	0.8494	1.450 (0.788)	0.0685	0.7211	0.314 (0.507)	0.5368
AAj	115	0.8503	1.613 (0.830)	0.0547	0.7156	0.097 (0.537)	0.8568
OBAg	116	0.8450	0.715 (14.159)	0.9598	0.7310	6.849 (8.870)	0.4418
OBAh	116	0.8451	0.613 (14.081)	0.9654	0.7325	6.380 (8.804)	0.4703
OBAi	116	0.8444	−0.037 (14.271)	0.9979	0.7212	5.984 (9.076)	0.5112
OBAj	115	0.8447	−1.666 (13.923)	0.9050	0.7156	1.754 (8.882)	0.8439
Σomega-6 PUFAg	116	0.8450	0.008 (0.453)	0.9864	0.7296	0.070 (0.282)	0.8036
Σomega-6 PUFAh	116	0.8451	0.001 (0.378)	0.9970	0.7311	−0.0001 (0.235)	0.9997
Σomega-6 PUFAi	116	0.8447	−0.167 (0.376)	0.6572	0.7226	−0.230 (0.237)	0.3355
Σomega-6 PUFAj	115	0.8452	−0.155 (0.283)	0.5856	0.7230	−0.294 (0.178)	0.1011
Omega-3/omega-6 PUFAk	116	0.8453	2.347 (2.633)	0.3748	0.7279	4.795 (1.652)	0.0045
EPA/LAk	116	0.8454	2.198 (2.400)	0.3619	0.7243	3.999 (1.517)	0.0097
DHA/LAk	116	0.8458	3.092 (2.927)	0.2934	0.7218	4.545 (1.859)	0.0162
Σomega-3 HPFA/LAk	116	0.8457	1.253 (1.229)	0.3105	0.7236	2.012 (0.778)	0.0111
EPA/AAk	116	0.8443	0.634 (1.842)	0.7315	0.7290	3.434 (1.152)	0.0036
DHA/AAk	116	0.8453	−1.798 (2.055)	0.3835	0.7088	1.397 (1.332)	0.2966
Σomega-3 HPFA/AAk	116	0.8442	−0.296 (1.010)	0.7704	0.7187	1.404 (0.642)	0.0310

^aModel adjusted for: other PUFA (see notes ^c to ^k), SOS_{year 2000}, age, menopausal status, weight, height, smoking, level of education, calcium supplements use, HRT use, oral contraceptive use, personal history of fracture (all measurements at baseline, year 2000).

^bModel adjusted for: other PUFA (see notes ^c to ^k), BUA _{year 2000}, age, menopausal status, weight, height, smoking, level of education, calcium supplement use, HRT use, oral contraceptive use, personal history of fracture (all measurements at baseline, year 2000).

^cPUFA for adjustment: Σomega-6 PUFA.

^dPUFA for adjustment: AA.

^ePUFA for adjustment: OBA.

^fPUFA for adjustment: LA.

^gPUFA for adjustment: Σomega-3 HPFA.

^hPUFA for adjustment: EPA.

ⁱPUFA for adjustment: DHA.

^jPUFA for adjustment: ALA.

^kModel adjusted for the variables indicated in notes ^a or ^b, and non-adjusted for another PUFA.